Correlation Between Regen BioPharma and Living Cell

Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regen BioPharma and Living Cell Technologies, you can compare the effects of market volatilities on Regen BioPharma and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Living Cell.

Diversification Opportunities for Regen BioPharma and Living Cell

-0.13

Correlation Coefficient

Regen BioPharma  Living Cell

Good diversification

The 3 months correlation between Regen and Living is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Living Cell go up and down completely randomly.

Pair Corralation between Regen BioPharma and Living Cell

Given the investment horizon of 90 days Regen BioPharma is expected to generate 6.1 times less return on investment than Living Cell. But when comparing it to its historical volatility, Regen BioPharma is 2.54 times less risky than Living Cell. It trades about 0.06 of its potential returns per unit of risk. Living Cell Technologies is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  0.16  in Living Cell Technologies on December 28, 2024 and sell it today you would earn a total of  0.24  from holding Living Cell Technologies or generate 150.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Regen BioPharma  vs.  Living Cell Technologies

Regen BioPharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Living Cell Technologies

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Living Cell Technologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Living Cell reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regen BioPharma and Living Cell

The main advantage of trading using opposite Regen BioPharma and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.

The idea behind Regen BioPharma and Living Cell Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.